UDG Healthcare Announces 8% Increase in Operating Profit
Dublin-based Healthcare services provider UDG released preliminary results of their financial year on Thursday, November 24, which showed an 8% increase in operating profit for continuing operations over 2015. The results for the year ending on September 30 show increases in revenue, operating profit, profit before tax, earnings before interest, taxes, depreciation and amortization (EBITDA) and diluted earnings per share.
The report showed UDG increased its revenue by 3% to €943 million a year, while it’s profits before tax jumped 11% to €75 million.
The report as showed the company makes a €132 million profit after tax for discontinued operations including United Drug Supply Chain Services, United Drug Sangers, TCP Group, MASTA and Magir Limited.
UDG’s main active division are Ashfield Commercial & Medical Services, Sharp Packaging Services, and Aquilant Supply Chain Services. Ashfield Commercial & Medical Services provides commercialisation services for the pharmaceutical and healthcare industry, operating across contract sales outsourcing, healthcare communications, and clinical solutions. Ashfield is the largest division of UDG Healthcare by profit contribution.
Sharp Packaging Services provides packaging and clinical trial supply chain solutions services for the pharmaceutical and biotechnology industries. Sharp employs almost 2,000 people across the United States and Europe.
